Pharmaceutical Business Capabilities Map | Capstera

Why Pharmaceutical Companies Need a Capabilities Map, Not Just a Drug Pipeline

Pharmaceutical Business Capabilities Map is a customizable, comprehensive, and in-depth set of business capabilities that captures the essence of what a pharmaceutical enterprise does — decomposed to ~325 capabilities across three levels.

Every pharmaceutical company has a drug pipeline. Fewer have the structural map connecting discovery, clinical trials, and regulatory affairs.

This capabilities map is a customizable, in-depth set of business capabilities capturing what a pharmaceutical company does — a blueprint spanning discovery through commercial launch.

Pharma Is Being Reshaped by AI-Accelerated Discovery

Rising R&D costs, patent cliffs, and the promise of AI-accelerated discovery are forcing pharmaceutical companies to rethink capabilities that were stable for decades.

A capability matrix gives companies a foundational entity to plan transformation around, rather than bolting a discovery-AI tool onto an unmapped R&D operation.

Why This Matters Even More in the Age of AI-Accelerated Drug Discovery

Every pharmaceutical leader is being asked how AI-driven molecule screening and predictive trial design fit into R&D. That question needs a capability-level answer, not a single discovery headline.

• Automation candidates: molecule screening, literature synthesis, regulatory document drafting support.
• Stay human: clinical trial design decisions, regulatory strategy, safety signal adjudication.
• Agentic boundaries: the capability map gives you the vocabulary to define what a discovery agent can generate versus what needs a scientist's review.

What's Inside

The map is delivered as a set of editable artifacts:

• Excel spreadsheet — the full pharmaceutical capability list, grouped by level.
• PowerPoint format — the top three levels presented as a nested visualization.
• Word document — capabilities in a multilevel list format for easy editing.
• Capability Definitions — definitions carried to Level 3.
• Capability KPIs — key performance indicators mapped to Level 2 capabilities.

Files in Your Download

• Pharmaceutical Business Capabilities Map — ZIP
• A Practical Guide to Business Architecture — PDF
• Business Architecture - Framework to Enablement — PowerPoint
• Business Architecture Deliverables List — PowerPoint
• Business Architecture Leader Expectations and Role — Word
• Business Capability Modeling Overview — PowerPoint
• Business Capability Summary Profile Template — PowerPoint
• Capabilities Relationship Mapping Templates — Excel
• Capabilities to Microservices Mapping Example — PowerPoint

Who It's For and How Teams Use It

This is a generic model, so it's a starting point rather than a finished product for every company in the following subsectors. A generic map spanning multiple sub-segments won't be specific to your exact niche — that's where our professional services team can help customize it, or you can tailor it internally.

• Large Pharmaceutical Manufacturers (Primary)
• Biotech and Specialty Pharma
• Generic Drug Manufacturers
• Contract Research Organizations

How Teams Put the Map to Work

• Business architects use the map as the baseline for a current-state capability assessment and as the base layer for maturity or investment heatmap overlays.
• Enterprise architects run footprint analysis — juxtaposing capabilities against systems and applications supports better application portfolio rationalization decisions.
• Strategy and transformation leads build capability-based roadmaps that eliminate redundancy and duplication, focusing on capability evolution rather than project execution.
• Consultants bring the map into workshops as a strawman, so client sessions start from a structured draft instead of a blank wall.
• Business and IT teams together use capabilities as a shared, everyday language — a structurally sound abstraction of business functions, independent of org chart, technology, or people.

Why Purchase a Business Capabilities Map

Starting from a blank slate: A blank whiteboard is the most expensive way to start a capability map. This one gets you to 60–80% coverage immediately, so internal effort goes toward the sector- and company-specific nuances that actually differentiate you.

Hiring a consulting firm: A comparable deliverable from a consulting engagement typically costs $100,000 or more, depending on the firm and geography.

This map: $999. Less than an inexpensive team dinner, and far less than the $100,000+ a consulting engagement typically costs for a comparable deliverable.

Even if you already have a capability map for the pharmaceutical sector, you can use this one to compare, validate, and potentially surface capabilities you're missing.

A Note About the Artifacts

Business Capabilities Matrix — A functional area occupies one box in many business capability maps. We decompose into 100X or more granular capabilities intentionally: one box on a one-page diagram is wall art, not an implementation tool. Some capabilities here may not be relevant to you; some of your own may not be captured.

Capability Definitions — We include definitions at a granular level we judge useful, not for every single capability — some are self-evident at that depth. Add, expand, or modify freely.

Capability KPIs — A starting set, mostly at Level 2, meant as a springboard. Your company may track an entirely different set of metrics — use these to get started, not as a debate about applicability.

Terms You Should Know Before Purchasing

We cannot accept refunds or returns, as these are digital deliverables, sold as-is with no implied or explicit warranties. The sale does not include customization or implementation help. Please review our standard Terms of Service — and note that a generic capability model may or may not be fully applicable to your company's specific circumstances.

Frequently Asked Questions

How detailed is the Pharmaceutical Business Capabilities Map?

The map decomposes what a pharmaceutical enterprise does into roughly 325 capabilities across three levels, spanning discovery through commercial launch. Capability definitions are carried to Level 3, and key performance indicators are mapped to Level 2 capabilities.

What file formats are included, and can I edit them?

The capability model is delivered in Excel (the full list grouped by level), PowerPoint (the top three levels as a nested visualization), and Word (a multilevel list). Everything is editable — you can add, remove, rename, and re-level capabilities to match your organization.

How much of the map will apply to my company as-is?

It is a generic model spanning large pharmaceutical manufacturers, biotech and specialty pharma, generic drug manufacturers, and contract research organizations, so treat it as a starting point rather than a finished product. Like most pre-built models, it typically covers roughly 60–80% of a typical organization's needs, with the remainder tailored internally or with outside help.

What is not included?

The purchase does not include customization or implementation services, and because these are digital deliverables there are no refunds, samples, or demos. If you need hands-on help adapting the map, our consulting team is available for paid engagements.

How does this map relate to the Pharmaceutical Business Architecture Reference Model?

The Pharmaceutical Business Architecture Reference Model is the complete reference model and includes this capability map. The Pharmaceutical Company Value Streams product is the companion value stream artifact if you want capabilities and value streams side by side.

How is the map licensed and delivered?

It is a perpetual one-time license. The Enterprise Edition covers one organization with unlimited internal users; the Consultancy Edition permits use across client engagements, with no resale. A secure download link is delivered immediately after checkout and by email, with 3 downloads per item and free updates to the product within 180 days of purchase.

For other licensing and delivery questions, see the Store FAQ.